| Dr Wei Deng |
| University of New South Wales |
| Cancer |
| Tool |
Key outcomes:
- Licensing agreement with EOSGene established
- Australia’s Economic Accelerator Grant (2026), $380,000
- ARC Grant Discovery Project Grant (2026), $658,729
- Received NHMRC Ideas grant worth $260,000 based on preliminary data from this research
- NSW Health grant, $160,000
- NSW Health RNA Future Leader Program, $160,000
- Received Cancer Institute of NSW career development fellowship, $517,000
- Received UNSW interlude grant, $66,000
“Dr Deng’s innovative technology stems from her research that photodynamic therapy (PDT) agents can be triggered by low dose x-ray radiation. The stimulated PDT agents produce active species which destabilise liposome structure and trigger the drug release from the liposomes. Inspired by this discovery, her team creatively combined two existing clinical techniques used in cancer treatment – radiation and chemotherapy – through a nanoparticle drug delivery system“